Dr. Mortimer specializes in industrial organization, health economics, microeconomic theory, and econometrics. He has provided economic analyses in a variety of industries, including software, pharmaceuticals, hospitals/wages, credit cards, and insurance. He has also supported Counsel on a number of government investigations related to marketing, physician payments, and pricing in the pharmaceutical and medical device industries. Dr. Mortimer has led analyses of large data sets to evaluate class certification, assess market definition, determine liability, and calculate damages. In government investigations he has evaluated factors contributing to off-label drug use or medical device adoption and presented analyses to investigators. Outside of litigation, Dr. Mortimer has also developed pricing analyses for pharmaceutical clients and collaborated with academics in authoring several public policy studies related to pharmaceutical and general health care legislation. Dr. Mortimer’s research prior to joining Analysis Group has addressed firm investment and cooperative incentives in the telecommunications and Internet industries.
